Aytu Biopharma Inc Revenue per Employee (AYTU), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Aytu Biopharma Inc  (NASDAQ: AYTU)
 

Aytu Biopharma Inc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Aytu Biopharma Inc's Revenue per employee fell on a trailing twelve month basis to $ 3,478,938, but the productivity of Aytu Biopharma Inc's employees remained above the company average.
Within the Healthcare sector Employees of 14 other companies have achieved higher revenue per employee. While Aytu Biopharma Inc's total ranking has deteriorated compared to the previous quarter from 28 to 234. Aytu Biopharma Inc has 16 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AYTU Revenue per Employee (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter		 (Mar 31 2025)
III. Quarter
Y / Y Revenue Change -34.86 % -7.36 % -17.51 % -14.03 % 0.64 %
Sales per Employee (TTM) $ 3,478,938 3,866,875 3,939,500 4,114,438 4,280,188
AYTU's Total Ranking # 234 # 28 # 219 # 233 # 218
Seq. Revenue Change -20.69 % 10.91 % -18.88 % -8.72 % 12.8 %

AYTU Company Profile >> Back to AYTU Efficiency Comparisons >> Compare AYTU Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 8
Healthcare Sector # 15
Overall Market # 234

Revenue per Employee Statistics
High Average Low
$ 6,664,500 $ 3,395,415 $ 225,020
(Jun 30 2023)   (Mar 31 2018)



Financial Statements
Aytu Biopharma Inc's Revenue MRQ $ 12 Millions Visit AYTU's Income Statement
Aytu Biopharma Inc's Revenues TTM $ 56 Millions Visit AYTU's aggregate revenue growth
What are AYTU's Sales? Visit AYTU's Sales by Segment




Other Ratios
Aytu Biopharma Inc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
AYTU's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for AYTU's Competitors
Revenue per Employee for AYTU's Suppliers
Revenue per Employee for AYTU's Customers

You may also want to know
AYTU's Sales Growth Rates AYTU's Pe Price to earnings ratio AYTU's Receivables Turnover Ratio AYTU's Stock Quote
AYTU's Net Income Growth Rates AYTU's Ps Price to Sales ratio AYTU's Sales per Employee AYTU's Asset Turnover Ratio
AYTU's Net Margin AYTU's Pb Price to Book ratio AYTU's Financial Strength Ratios AYTU's Dividend Payout Ratio
Date modified: 2026-08-29T17:22:18+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2026Number of Employees Mar 31 2026
Ligand Pharmaceuticals Incorporated  5,839,914.89 $ 274.476  Million 47 
Anika Therapeutics Inc   5,529,666.67 $ 116.123  Million 21 
Xeris Biopharma Holdings Inc   4,843,892.31 $ 314.853  Million 65 
P3 Health Partners Inc   4,600,765.62 $ 1,472.245  Million 320 
Community Health Systems Inc   3,964,838.71 $ 12,291.000  Million 3,100 
Vaxart Inc   3,932,446.15 $ 255.609  Million 65 
Ironwood Pharmaceuticals inc   3,615,140.00 $ 361.514  Million 100 
Halozyme Therapeutics Inc   3,566,094.56 $ 1,508.458  Million 423 
Amgen Inc   3,489,923.08 $ 45,369.000  Million 13,000 
Aytu Biopharma Inc  3,478,937.50 $ 55.663  Million 16 
Xoma Royalty Corporation  3,468,214.29 $ 48.555  Million 14 
Illumina Inc   3,432,031.25 $ 4,393.000  Million 1,280 
Therapeuticsmd Inc   3,353,000.00 $ 3.353  Million 1 
Nuvation Bio Inc   3,305,139.53 $ 142.121  Million 43 
Catalyst Pharmaceuticals Inc   3,279,989.01 $ 596.958  Million 182 
Harmony Biosciences Holdings inc   3,069,102.39 $ 899.247  Million 293 
Sarepta Therapeutics Inc   2,615,789.22 $ 2,184.184  Million 835 
Innoviva Inc   2,479,150.94 $ 394.185  Million 159 
Spero Therapeutics Inc   2,447,440.00 $ 61.186  Million 25 
Aurinia Pharmaceuticals Inc   2,330,429.69 $ 298.295  Million 128 
United Therapeutics Corporation  2,264,142.86 $ 3,169.800  Million 1,400 
Elite Pharmaceuticals Inc   2,261,542.74 $ 147.000  Million 65 
Anaptysbio Inc   2,234,500.00 $ 232.388  Million 104 
Exelixis Inc   2,071,047.08 $ 2,375.491  Million 1,147 
Kiniksa Pharmaceuticals International Plc  2,060,232.24 $ 754.045  Million 366 
Cormedix Inc   2,040,572.14 $ 389.749  Million 191 
Biocryst Pharmaceuticals Inc   2,036,128.74 $ 885.716  Million 435 
Eton Pharmaceuticals Inc   1,968,500.00 $ 86.614  Million 44 
Assertio Holdings inc   1,927,509.43 $ 102.158  Million 53 
Siga Technologies Inc  1,913,809.53 $ 93.777  Million 49 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.